| 摘要 |
The present invention relates to atenolol-based drugs intended for beta receptor blockade and for treatment of hypertension, and also a method for reducing, with the aid of these drugs, the toxic effect upon drug treatment in order to achieve the desired level of beta receptor blockade or the desired reduction in blood pressure upon drug treatment for hypertension. |
